Prof. Dr. Markus Neurath



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Gut Pathobiont–Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis–Associated Inflammatory Bowel Disease (2024) Dorner H, Stolzer I, Mattner J, Kaminski S, Leistl S, Edrich LM, Schwendner R, et al. Journal article A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center. (2024) Cuba L, Dürr P, Geßner K, Häcker B, Fietkau R, Siebler J, Pavel ME, et al. Journal article Alzheimer’s disease-related presenilins are key to intestinal epithelial cell function and gut immune homoeostasis (2024) Erkert L, Gamez-Belmonte R, Kabisch M, Schödel L, Patankar J, Gonzalez Acera M, Mahapatro M, et al. Journal article Cellular immunotherapies and immune cell depleting therapies in inflammatory bowel diseases: the next magic bullet? (2024) Neurath M, Sands BE, Rieder F Journal article Tofacitinib Affects M1-like and M2-like Polarization and Tissue Factor Expression in Macrophages of Healthy Donors and IBD Patients. (2024) Lethen I, Lechner-Grimm K, Gabel M, Knauß A, Atreya R, Neurath M, Weigmann B Journal article Teachability of multispectral optoacoustic tomography (2024) Li Y, Gröhl J, Haney B, Caranovic M, Lorenz-Meyer E, Papatheodorou N, Kempf J, et al. Journal article Strategies for targeting cytokines in inflammatory bowel disease (2024) Neurath M Journal article, Review article The Proteomic Signature of Tissue Remodeling in Chronic Intestinal Inflammation (2024) Neurath M Journal article Biomarkers for Personalizing IBD Therapy: The Quest Continues (2024) Atreya R, Neurath M Journal article, Review article Submucosal Injection of the RNA Oligonucleotide GUT-1 in Active Ulcerative Colitis Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Induction Trial. (2024) Atreya R, Kühbacher T, Waldner M, Hirschmann S, Drvarov O, Abu Hashem R, Maaser C, et al. Journal article